Skip to main content

Table 3 Expression of EZH2 in subtype of breast carcinoma

From: EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features

Clinicopathologic features

EZH2 score

  
 

Total N

>3 score, positive

9 score, positive

P value

ER positive with low Ki67

54

18.5 % (10/54)

0 % (0/10)

p < 0.001

ER positive with high Ki67

67

61.2 % (41/67)

51.2 % (21/41)

Her2 positive

50

74 % (37/50)

51.4 % (19/37)

Triple-negative

55

90.9 % (50/55)

88 % (44/50)

Total

226

61.1 % (138/226)

62.3 % (86/138)